← Browse by Condition
Medical Condition

tobacco use

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for tobacco use sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — tobacco use Clinical Trials

How many clinical trials are currently recruiting for tobacco use?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for tobacco use, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for tobacco use?
tobacco use research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a tobacco use clinical trial?
Eligibility criteria for tobacco use trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Penn State University 1 trial
Washington University School of Medicine 1 trial
University of Oklahoma 1 trial
Loma Linda University 1 trial
Milton S. Hershey Medical Center 1 trial

Recruiting Clinical Trials

NCT05572671
Recruiting

Linking Brain Network Dynamics to Imminent Smoking Lapse Risk and Behavior

Enrollment
150 pts
Location
United States
Sponsor
Penn State University
View Trial →
NCT07020273
Recruiting

CONNECT Cancer Survivors With Tobacco Treatment

Enrollment
5,000 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
NCT06986993 Phase 4
Recruiting

Impact of Semaglutide on Tobacco Use and Related Health Behaviors

Enrollment
40 pts
Location
United States
Sponsor
University of Oklahoma
View Trial →
NCT06438549
Recruiting

Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation

Enrollment
105 pts
Location
United States
Sponsor
Loma Linda University
View Trial →
NCT06310187
Recruiting

Little Cigar Oxidants

Enrollment
50 pts
Location
United States
Sponsor
Milton S. Hershey Medical Cent...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology